Dr. Dostou is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 Meadowmont Village Cir
Chapel Hill, NC 27517Phone+1 984-974-2950Fax+1 984-974-2924
Education & Training
- University of RochesterFellowship, Endocrinology, Diabetes, and Metabolism, 1995 - 1998
- University of RochesterResidency, Internal Medicine, 1992 - 1995
- The Warren Alpert Medical School of Brown UniversityClass of 1992
Certifications & Licensure
- NC State Medical License 1998 - 2025
- NY State Medical License 1994 - 2000
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
- Fellow (FACE) American Association of Clinical Endocrinology
Publications & Presentations
PubMed
- 36 citationsMulticenter, Randomized Trial of a Bionic Pancreas in Type 1 Diabetes., Steven J Russell, Roy W Beck, Edward R Damiano, Firas H El-Khatib
The New England Journal of Medicine. 2022-09-29 - 72 citationsAnti-interleukin-21 antibody and liraglutide for the preservation of β-cell function in adults with recent-onset type 1 diabetes: a randomised, double-blind, placebo-c...Matthias von Herrath, Stephen C. Bain, Bruce W. Bode, Jesper Ole Clausen, Ken Coppieters
The Lancet. Diabetes & Endocrinology. 2021-04-01 - 201 citationsAlefacept provides sustained clinical and immunological effects in new-onset type 1 diabetes patientsMark R. Rigby, Kristina M. Harris, Ashley Pinckney, Linda A. DiMeglio, Marc Rendell
The Journal of Clinical Investigation. 2015-08-03
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: